title: Use of NCCN Guidelines, Other Guidelines, and Biomarkers for Colorectal Cancer Screening.
abstract: Colorectal cancer (CRC) remains a common cancer and significant public health burden. CRC-related mortality is declining, partly due to the early detection of CRC through robust screening. NCCN has established the NCCN Guidelines for CRC Screening to help healthcare providers make appropriate screening recommendations according to the patient's risk of developing CRC. This review describes the evolution of CRC screening guidelines for average-risk individuals, discusses the role of NCCN Guidelines for CRC Screening in cancer prevention, and comments on the current and emerging use of biomarkers for CRC screening.
authors: From Cooperative Studies Program Epidemiology Center-Durham, Durham VA Medical Center, and Division of Medical Oncology, Duke University Medical Center, Durham, North Carolina; Clinical Research Division, Fred Hutchison Cancer Research Center, and Department of Medicine, University of Washington, Seattle, Washington; and Center for Health Services Research in Primary Care, Durham VA Medical Center, and Division of General Internal Medicine, Duke University Medical Center, Durham, North Carolina.|From Cooperative Studies Program Epidemiology Center-Durham, Durham VA Medical Center, and Division of Medical Oncology, Duke University Medical Center, Durham, North Carolina; Clinical Research Division, Fred Hutchison Cancer Research Center, and Department of Medicine, University of Washington, Seattle, Washington; and Center for Health Services Research in Primary Care, Durham VA Medical Center, and Division of General Internal Medicine, Duke University Medical Center, Durham, North Carolina.
authors: Christina D
authors: CD
authors: Williams
authors: From Cooperative Studies Program Epidemiology Center-Durham, Durham VA Medical Center, and Division of Medical Oncology, Duke University Medical Center, Durham, North Carolina; Clinical Research Division, Fred Hutchison Cancer Research Center, and Department of Medicine, University of Washington, Seattle, Washington; and Center for Health Services Research in Primary Care, Durham VA Medical Center, and Division of General Internal Medicine, Duke University Medical Center, Durham, North Carolina.|From Cooperative Studies Program Epidemiology Center-Durham, Durham VA Medical Center, and Division of Medical Oncology, Duke University Medical Center, Durham, North Carolina; Clinical Research Division, Fred Hutchison Cancer Research Center, and Department of Medicine, University of Washington, Seattle, Washington; and Center for Health Services Research in Primary Care, Durham VA Medical Center, and Division of General Internal Medicine, Duke University Medical Center, Durham, North Carolina.
authors: William M
authors: WM
authors: Grady
authors: From Cooperative Studies Program Epidemiology Center-Durham, Durham VA Medical Center, and Division of Medical Oncology, Duke University Medical Center, Durham, North Carolina; Clinical Research Division, Fred Hutchison Cancer Research Center, and Department of Medicine, University of Washington, Seattle, Washington; and Center for Health Services Research in Primary Care, Durham VA Medical Center, and Division of General Internal Medicine, Duke University Medical Center, Durham, North Carolina.|From Cooperative Studies Program Epidemiology Center-Durham, Durham VA Medical Center, and Division of Medical Oncology, Duke University Medical Center, Durham, North Carolina; Clinical Research Division, Fred Hutchison Cancer Research Center, and Department of Medicine, University of Washington, Seattle, Washington; and Center for Health Services Research in Primary Care, Durham VA Medical Center, and Division of General Internal Medicine, Duke University Medical Center, Durham, North Carolina.
authors: Leah L
authors: LL
authors: Zullig
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D015179:Colorectal Neoplasms / Q000737:chemistry / Q000175:diagnosis*; D055088:Early Detection of Cancer / Q000379:methods / Q000592:standards*; D006801:Humans; D008403:Mass Screening / Q000379:methods*
chemical_list: D014408:Biomarkers, Tumor